- Home
- ACXP vs XWEL Comparison
ACXP vs XWEL Comparison
Compare ACXP & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- XWEL
- Stock Information
- Founded
- ACXP 2017
- XWEL 2006
- Country
- ACXP United States
- XWEL United States
- Employees
- ACXP N/A
- XWEL N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- XWEL Other Consumer Services
- Sector
- ACXP Health Care
- XWEL Consumer Discretionary
- Exchange
- ACXP Nasdaq
- XWEL Nasdaq
- Market Cap
- ACXP 6.8M
- XWEL 6.2M
- IPO Year
- ACXP 2021
- XWEL N/A
- Fundamental
- Price
- ACXP $4.24
- XWEL $0.99
- Analyst Decision
- ACXP Strong Buy
- XWEL
- Analyst Count
- ACXP 3
- XWEL 0
- Target Price
- ACXP $143.67
- XWEL N/A
- AVG Volume (30 Days)
- ACXP 89.0K
- XWEL 30.2K
- Earning Date
- ACXP 11-12-2025
- XWEL 11-13-2025
- Dividend Yield
- ACXP N/A
- XWEL N/A
- EPS Growth
- ACXP N/A
- XWEL N/A
- EPS
- ACXP N/A
- XWEL N/A
- Revenue
- ACXP N/A
- XWEL $30,601,000.00
- Revenue This Year
- ACXP N/A
- XWEL N/A
- Revenue Next Year
- ACXP N/A
- XWEL N/A
- P/E Ratio
- ACXP N/A
- XWEL N/A
- Revenue Growth
- ACXP N/A
- XWEL N/A
- 52 Week Low
- ACXP $3.80
- XWEL $0.70
- 52 Week High
- ACXP $43.20
- XWEL $2.00
- Technical
- Relative Strength Index (RSI)
- ACXP 51.39
- XWEL 40.51
- Support Level
- ACXP $3.97
- XWEL $0.97
- Resistance Level
- ACXP $4.85
- XWEL $1.02
- Average True Range (ATR)
- ACXP 0.35
- XWEL 0.07
- MACD
- ACXP -0.02
- XWEL -0.01
- Stochastic Oscillator
- ACXP 23.45
- XWEL 9.59
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers with premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.